# Enovix Corporation (ENVX) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Technology / Electronic Equipment, Instruments & Components. Price $3.32, market value $729 million.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Enovix Corporation reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 20.3×**. Each dollar of revenue is priced at 20.3×, a level that requires very high margins or very fast growth to justify.
- **Price / book: 3.4×**. The shares trade at 3.4× book value; book value is a meaningful part of the valuation.
- **Free-cash-flow yield: -17.0%** (5-yr avg -6.6%). Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Gross margin: 18.8%**. Enovix Corporation keeps 18.8% of revenue after the direct cost of what it sells, a thin margin typical of retail, distribution and commodity businesses.
- **Operating margin: -496.5%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -492.6%**. The company reported a net loss over the last twelve months.
- **Return on equity: -57.8%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -20.3%**. Return on all capital, debt included, is -20.3%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -19.3%**. Each dollar of assets produces -19.3% of profit.

## Growth
- **Revenue growth (1 yr): 37.9%** (3-yr 72.5%/yr). Revenue grew 37.9% over the last year.
- **EPS growth (1 yr): 37.0%**. Earnings per share rose 37.0%, roughly in step with revenue.

## Financial health
- **Debt to equity: 1.95**. Debt is 1.95 times equity, a leveraged balance sheet that needs steady cash flow to service.
- **Net debt / EBITDA: net cash**. Enovix Corporation holds more cash than debt.
- **Altman Z-score: 0.53**. A Z-score of 0.53 is in the distress zone, a signal to examine the balance sheet closely.
- **Piotroski F-score: 3/9**. 3 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Enovix Corporation does not currently pay a dividend.

## Analyst view
- **Analyst consensus: buy** (10 analysts). 10 analysts cover Enovix Corporation; the consensus is buy, with an average price target of $11.35 (+242% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -63.2%** (YTD -54.6%, 3-mo -54.4%). The shares are down 63.2% over twelve months including dividends.
- **From 52-week high: -76.6%** (8.5% above the low). Trading 77% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 38**. An RSI of 38 is neutral.
- **Beta (1 yr): 3.62** (volatility 88%). Beta of 3.62 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=ENVX · Page: https://foliofundamentals.com/stocks/envx

Not investment advice.